AN OPEN LABEL SINGLE ARM CLINICAL STUDY TO EVALUATE THE EFFICACY OF AMALAKI RASAYANA IN THE MANAGEMENT OF MENOPAUSAL SYNDROME
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 100
- 试验地点
- 1
研究概览
简要总结
MENOPAUSE DEFINES A PERMANENT CESSATION OF MENSTRUATION AT THE END OF REPRODUCTIVE LIFE DUE TO LOSS OF OVARIAN FOLLICULAR ACTIVITY AYURVEDIC LITERATURE HAS MENTIONED MENOPAUSE AS NATURAL PHENOMENON IN LIFE OF WOMEN AS RAJONIVRITI AND DEPICTED AS JARAPAKRA AVASTHATHE DIAGNOSIS OF MENOPAUSE IS NOT MADE UNTIL THE INDIVIDUAL HAS HAD TWELVE MONTHS OF AMENORRHEA THIS OPEN LABEL SINGLE ARM CLINICAL STUDY AIMS TO EVALUATE THE EFFICACY OF AMALAKI RASAYANA IN MANAGEMENT OF MENOPAUSAL SYNDROME A TOTAL OF HUNDRED PATIENTS WITH MENOPAUSAL SYMPTOMS WILL BE ENROLLED AND TREATED WITH AMALAKI RASAYANA TEN GRAM BD FOR FORTY FIVE DAYS THE EFFECT OF INTERVENTION WILL BE ASSESSED USING SIGNS AND SYMPTOMS OF MENOPAUSAL SYNDROME AND BIOCHEMICAL PARAMETERS SUCH AS SERUM ESTRADIOL AND SERUM CALCIUM THE STUDY INTENDS OF AMALAKI RASAYANA IN REDUCING MENOPAUSAL SYMPTOMS AND IMPROVING QUALITY OF LIFE
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 盲法
- None
入排标准
- 年龄范围
- 45.00 Year(s) 至 55.00 Year(s)（—）
- 性别
- Female
入选标准
- •AMENORRHEA MORE OR OF TWELVE MONTHS SERUM ESTRADIOL LEVEL LESS THAN TWENTY pg PER ml PATIENTS WITH SIGNS AND SYMPTOMS OF MENOPAUSE WITH SIGNED INFORMED CONSENT.
排除标准
- •PATIENT NOT WILLING TO PARTICIPATE IN CLINICAL TRIAL PATIENTS WITH DOCUMENTED HISTORY OF MALIGNANCY DIABETES HTN OR ANY OTHER MAJOR SYMPTOMATIC ILLNESS PATIENTS ON PROLONGED MEDICATIONS ON CORTICOSTEROIDS ANTIDEPRESSANT TUBERCULAR DRUGS ETC PATIENT HAVING AGE LESS THAN FORTY YEARS AND MORE THAN FIFTY FIVE YEARS PATIENT WITH ANY HISORY OF ORGANIC PELVIC LESION LIKE FIBROID UTERUS PELVIC INFLAMMATORY DISEASE.
研究者
DR PRIYANKA
INSTITUTE FOR AYURVEDA STUDIES AND RESEARCH